Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (161-170 of 331) with videos related to

Pageof 34
Sort By:
European Eating Disorders Review : the Journal of the Eating Disorders Association|May 27, 2026
Eating Disorders and Parkinson's Disease-1: Comorbidities, Neurobiology, and Family HistoryAngeline Krueger, Andrew W Bergen, Irene Litvan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 11, 2019
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndromeNobutaka Sakae, Keith A Josephs, Irene Litvan, et al.
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Parkinsonism & Related Disorders|October 31, 2019
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?Ali Shoeibi, Irene Litvan, Jorge L Juncos, et al.
Neurology|December 29, 2019
Unique white matter structural connectivity in early-stage drug-naive Parkinson diseaseVirendra R Mishra, Karthik R Sreenivasan, Zhengshi Yang, et al.
The Lancet. Neurology|February 20, 2021
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialGünter U Höglinger, Irene Litvan, Nuno Mendonca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2010
A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophyAnette Schrag, Shamira Sheikh, Niall P Quinn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Research goals in progressive supranuclear palsyIrene Litvan, Dennis W Dickson, Jean A Buttner-Ennever, et al.
Brain : a Journal of Neurology|September 22, 2011
Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndromeNaomi Kouri, Melissa E Murray, Anhar Hassan, et al.
Parkinsonism & Related Disorders|January 9, 2018
Anti-inflammatory drug use and progressive supranuclear palsyConnie Marras, Christopher R Cunningham, Jiayi Hou, et al.
Pageof 34

Showing results (161-170 of 331) with videos related to

Sort By:
Pageof 34
European Eating Disorders Review : the Journal of the Eating Disorders Association|May 27, 2026
Eating Disorders and Parkinson's Disease-1: Comorbidities, Neurobiology, and Family HistoryAngeline Krueger, Andrew W Bergen, Irene Litvan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 11, 2019
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndromeNobutaka Sakae, Keith A Josephs, Irene Litvan, et al.
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Parkinsonism & Related Disorders|October 31, 2019
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?Ali Shoeibi, Irene Litvan, Jorge L Juncos, et al.
Neurology|December 29, 2019
Unique white matter structural connectivity in early-stage drug-naive Parkinson diseaseVirendra R Mishra, Karthik R Sreenivasan, Zhengshi Yang, et al.
The Lancet. Neurology|February 20, 2021
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialGünter U Höglinger, Irene Litvan, Nuno Mendonca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2010
A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophyAnette Schrag, Shamira Sheikh, Niall P Quinn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Research goals in progressive supranuclear palsyIrene Litvan, Dennis W Dickson, Jean A Buttner-Ennever, et al.
Brain : a Journal of Neurology|September 22, 2011
Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndromeNaomi Kouri, Melissa E Murray, Anhar Hassan, et al.
Parkinsonism & Related Disorders|January 9, 2018
Anti-inflammatory drug use and progressive supranuclear palsyConnie Marras, Christopher R Cunningham, Jiayi Hou, et al.
Pageof 34